253 related articles for article (PubMed ID: 31446751)
1. The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study.
Barman HA; İkitimur B; Kılıçkıran Avcı B; Durmaz E; Atıcı A; Aslan S; Ceylaner S; Karpuz H
Balkan Med J; 2019 Oct; 36(6):354-358. PubMed ID: 31446751
[TBL] [Abstract][Full Text] [Related]
2. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy.
Frustaci A; Borghetti V; Pentiricci S; Verardo R; Scialla R; Russo MA
ESC Heart Fail; 2023 Dec; 10(6):3710-3713. PubMed ID: 37715354
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
7. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
Sachdev B; Takenaka T; Teraguchi H; Tei C; Lee P; McKenna WJ; Elliott PM
Circulation; 2002 Mar; 105(12):1407-11. PubMed ID: 11914245
[TBL] [Abstract][Full Text] [Related]
9. α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.
Oder D; Liu D; Hu K; Üçeyler N; Salinger T; Müntze J; Lorenz K; Kandolf R; Gröne HJ; Sommer C; Ertl G; Wanner C; Nordbeck P
Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29018006
[TBL] [Abstract][Full Text] [Related]
10. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
11. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey.
Barman HA; Özcan S; Atıcı A; Özgökçe C; Öztürk A; Kafalı AE; Çakar NE; Tavşanlı ME; Küçük M; Şahin I; Okuyan E
Anatol J Cardiol; 2020 Jan; 23(2):79-85. PubMed ID: 32011328
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic features of Fabry cardiomyopathy-Comparison with hypertrophy-matched sarcomeric hypertrophic cardiomyopathy.
Militaru S; Jurcuț R; Adam R; Roşca M; Ginghina C; Popescu BA
Echocardiography; 2019 Nov; 36(11):2041-2049. PubMed ID: 31661576
[TBL] [Abstract][Full Text] [Related]
13. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation.
Baptista A; Magalhães P; Leão S; Carvalho S; Mateus P; Moreira I
Arq Bras Cardiol; 2015 Aug; 105(2):139-44. PubMed ID: 26269958
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.
Elliott P; Baker R; Pasquale F; Quarta G; Ebrahim H; Mehta AB; Hughes DA;
Heart; 2011 Dec; 97(23):1957-60. PubMed ID: 21890869
[TBL] [Abstract][Full Text] [Related]
16. Fabry disease in cardiology practice: Literature review and expert point of view.
Hagège A; Réant P; Habib G; Damy T; Barone-Rochette G; Soulat G; Donal E; Germain DP
Arch Cardiovasc Dis; 2019 Apr; 112(4):278-287. PubMed ID: 30826269
[TBL] [Abstract][Full Text] [Related]
17. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
Junqua N; Legallois D; Segard S; Lairez O; Réant P; Goizet C; Maillard H; Charron P; Milliez P; Labombarda F
Arch Cardiovasc Dis; 2020; 113(8-9):542-550. PubMed ID: 32771348
[TBL] [Abstract][Full Text] [Related]
18. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.
Cerrato F; Pacileo G; Limongelli G; Gagliardi MG; Santoro G; Digilio MC; Di Salvo G; Ardorisio R; Miele T; Calabrò R
Cardiol Young; 2008 Dec; 18(6):575-80. PubMed ID: 18842161
[TBL] [Abstract][Full Text] [Related]
19. Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy.
Dimitrow PP; Czarnecka D; Strojny JA; Kawecka-Jaszcz K; Dubiel JS
Int J Cardiol; 2001 Jan; 77(1):43-8. PubMed ID: 11150624
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
